The placement of pointed cranial pins into the periosteum is a recognized acute noxious stimulation during intracranial surgery which can result in sudden increases in blood pressure and heart rate, causing increases in intracranial pressure. A skull block (blockade of the nerves that innervate the scalp, including the greater and lesser occipital nerves, the supraorbital and supratrochlear nerves, the auriculotemporal nerves, and the greater auricular nerves) may be effective in reducing hypertension and tachycardia. Twenty-one patients were allocated in a prospective, double-blind fashion to a control group or a bupivacaine group. After a standardized induction and 5 min prior to head pinning, a skull block was performed. Patients in the control group received a skull block of normal saline, while the bupivacaine group received a skull block with 0.5% bupivacaine.
The placement of pointed cranial pins into the periosteum is a recognized acute noxious stimulation during intracranial surgery which can result in sudden increases in blood pressure and heart rate, causing increases in intracranial pressure. A skull block (blockade of the nerves that innervate the scalp, including the greater and lesser occipital nerves, the supraorbital and supratrochlear nerves, the auriculotemporal nerves, and the greater auricular nerves) may be effective in reducing hypertension and tachycardia. Twenty-one patients were allocated in a prospective, double-blind fashion to a control group or a bupivacaine group. After a standardized induction and 5 min prior to head pinning, a skull block was performed. Patients in the control group received a skull block of normal saline, while the bupivacaine group received a skull block with 0.5% bupivacaine.
Systolic (SAP), diastolic (DAP), mean arterial pressure (MAP), heart rate (HR), and end-tidal isoflurane were recorded at the following times: 5 min after the induction of anesthesia, during performance of the skull block, during head pinning, and 5 min after head pinning. Significant increases in SAP of 40 +-6 mm Hg, DAP of 30 +-5 mm Hg, MAP of 32 -C 6 mm Hg, and HR of 22 + 5 bpm occurred during head pinning in the control group, while remaining unchanged in the bupivacaine group. These results demonstrate that a skull block using 0.5% bupivacaine successfully blunts the hemodynamic response to head pinning. (Anesth Analg 1996; 83:1256-61) I ntracranial surgery on patients with increased intracranial pressure (ICI') poses a unique challenge to the anesthesiologist. Although much intracranial surgery is not particularly stimulating, certain aspects of the operation, including laryngoscopy, insertion of cranial pins, incision, and periosteal-dural contact, induce noxious stimulation. These noxious events can result in sudden increases in blood pressure and heart rate (HR), which can cause potential morbidity due to further increases in ICI' in patients with intracranial pathology, and a greater risk for rupture in patients with intravascular aneurysms (1). Therefore, a method to blunt these noxious stimuli would be valuable. Blockade of the nerves that supply the involved region of the scalp may be effective in reducing hypertension and tachycardia, the requirement for vasodilators, and the requirement for an increased depth of anesthesia early in the surgical procedure, all of which may cause increased cerebral blood flow and an increase in ICI' (23. the time necessary for isoflurane end-tidal concentration to change. Isoflurane was monitored continuously after induction of anesthesia via Raman spectroscopy (Ohmeda Rascal II, Madison, WI>.
After induction of anesthesia, baseline hemodynamic variables were recorded and the skull block was performed 5 min before head pinning. The supraorbital and supratrochlear nerves were blocked with 2 mL of solution as they emerged from the orbit with a 23-gauge needle introduced above the eyebrow perpendicular to the skin. The auriculotemporal nerves were blocked bilaterally with 5 mL of solution injected 1.5 cm anterior to the ear at the level of the tragus; the needle was introduced perpendicular to the skin and infiltration was made deep to the fascia and superficially as the needle was withdrawn.
The postauricular branches of the greater auricular nerves were blocked with 2 mL of solution between skin and bone, 1.5 cm posterior to the ear at the level of the tragus (Figure 1 ). The greater, lesser, and third occipital nerves were blocked with 5 mL of solution using a 22-gauge spinal needle, with infiltration along the superior nuchal line, approximately halfway between the occipital protuberance and the mastoid process (Figure 2) .
A MayfieldTM head holder was used for all of the craniotomies in the study. The MayfieldTM head holder uses pointed pins that are inserted simultaneously through the dermis engaging in the periosteum to secure the head in a stable position for surgery. CRANIOTOMY 1996; 83:1256-61 At the time of head pinning, if the HR or MAP increased by more than 20% over baseline, the following rescue maneuvers were performed. The anesthesiologist would first attempt to control the blood pressure and/or HR with an increase in concentration of isoflurane to a maximum concentration of 1 minimum alveolar anesthetic concentration (MAC) (1.15% endtidal concentration).
If the MAP or HR remained greater than 20% over baseline values, the patient was given a single dose of STP (2 "g/kg).
An esmolol bolus of 0.5 mg/kg was then administered if prior maneuvers were not successful.
The difference in mean age between the two drug groups was tested for statistical significance by the Student's t-test. The Fisher's exact test was used to determine the significance of the distribution of men and women in the two drug groups.
Repeated-measured analysis of variance was applied to the baseline-adjusted measurements of SAP, DAP, MAP, HR, and ET-Is0 obtained during skull block, head pinning, and at 5 min after pinning.
An (Y level of 0.01 was used to determine the significance of each test result to account for the fact that five related measurements were examined using the same data. However, for the reader's benefit, the exact P values yielded by the statistical tests are provided in the following section. All statistical analysis were performed using the software (SAS/STAT@ software; SAS, Inc., Cary, NC). Results are presented as mean '-SEM.
Results
The mean ages for the 11 patients in the bupivacaine group and the 10 patients in the control group were 57 + 4.1 yr and 45 ? 4.7 yr, respectively (P = not significant).
Thirty-six percent (4 of 11) of the bupivacaine group and 20% (2 of 10) of the control group were men (P = not significant).
However, the small size of the group provided low power for detecting differences in age or gender. Past medical history was significant for hypertension in 3 of 11 patients in the bupivacaine group and 1 of 10 patients in the control group. All patients underwent elective craniotomy for tumor removal. Table 1 presents the mean & SEM values for the five measurements for each drug group at baseline. The results of the univariate analyses of the difference in the means are also presented. Although at baseline, the mean difference between the two groups was significant (P = 0.01) for DAP, the two groups had similar mean values of SAP, MAP, HR, and ET-Iso. The HR for both bupivacaine and control groups after anesthetic induction averaged 71 2 3 bpm. Moreover, the percent concentration of ET-Is0 for the bupivaCaine and control groups at baseline were similar (0.58% + 0.06% vs 0.72% +-0.06%, respectively). The results of the repeated-measured analyses of variance on the baseline-subtracted measurements on each of the five variables are provided in Table 2 . The positive values in the table indicate increases over the corresponding baseline values for the variable. During placement of the skull block there was no significant change from baseline in either the bupivacaine or control group with respect to HR, or SAP, DAP, and MAP (Table 2) . Moreover no additional isoflurane was required relative to baseline for either treatment group during the placement of the skull block. There was also no difference between the two treatment groups in any of the blood pressure values during placement of the skull block. For the bupivacaine and control groups, respectively, HR (73 + 3.8 bpm vs 79 + 3.5 bpm) and ET-Is0 concentration (0.60% + 0.06% vs 0.72% ? 0.07%) were also similar.
Significant increases in hemodynamic variables occurred during head pinning in the control group relative to baseline values (Table 2) . SAP increased by 40 -t 6 mm Hg and DAP by 30 + 5 mm Hg from baseline during pinning in patients in the control group (Table 2 ). There were also significant increases in MAP (32 t 6 mm Hg) and HR (22 ? 3 bpm) during pinning in the control group. An increase in the requirement for isoflurane at pinning over baseline values was also observed in the control group (ET-Is0 pinning 1.05% 2 0.12% vs ET-Is0 baseline 0.72% t 0.06%). Thus, despite a significant increase in anesthetic concentration in the control group, there was a significant change in hemodynamic variables. ET-Is0 was also unchanged during pinning, indicating no requirement for additional anesthesia in the bupivaCaine group.
Significant overall drug effect as well as time effect were observed in all variables except ET-Iso. The control group had substantially higher values of baselineadjusted hemodynamic variables at all three time points compared to the bupivacaine group.
Rescue maneuvers during pinning were not required in any patient in the bupivacaine group. Nine of the 10 patients in the control group required rescue with STP. Two of the nine patients also required intervention with esmolol.
Discussion
Acute increases in HR and arterial blood pressure can be deleterious in the neurosurgical patient with increased ICI' or with cerebral aneurysms (4). Acute arterial hypertension can further increase ICI' with a risk for herniation, and may also result in pulmonary edema and ruptured cerebral aneurysms (5). Therefore, prevention of acute hypertension in the neurosurgical patient due to noxious stimuli such as head pinning would be desirable. The present study demonstrates that a skull block with 0.5% bupivacaine attenuates hypertension and tachycardia seen during head pinning. The most significant findings of the present study were that a skull block can attenuate the hemodynamic response associated with head pinning, and that a skull block removes the requirement for additional anesthesia or vasoactive drugs during the period of head pinning. Therefore, this study demonstrates for the first time that addition of a skull block to the anesthetic plan for patients undergoing craniotomy will successfully prevent the hyperdynamic response to head pinning without increasing the requirement for volatile anesthetics or antihypertensive drugs. The use of local anesthetics as an adjunct in the anesthetic management of the patient presenting for craniotomy has been previously reported. Hillman et al. (2) reported successful hemodynamic attenuation with 0.5% bupivacaine without vasoconstrictor. In this study, the surgeon infiltrated the local anesthetic along the incision line and along the proposed scalp flap line. There was notable cardiovascular stability in the bupivacaine group. However, the study did not include placement of head holding pins as a time point. Hartley et al. (13) had similar finding in a pediatric patient presenting for craniotomy. This study again used skin infiltration by the neurosurgeon but there was no reference to the use of head holding pins. Rubial et al. (3) performed regional blockade of the occipital and frontal nerves and found it to be a useful method for maintaining hemodynamic stability during head pin placement. This study included a group of patients that had infiltration of local anesthetic at the pin site. There was also hemodynamic attenuation to pin placement in this group when compared to the baseline.
Isoflurane is a volatile anesthetic that has the potential to increase cerebral blood flow, cerebral blood volume, and ICI' (7). Despite these undesirable properties, isoflurane is a safe inhalational anesthetic for neuroanesthesia. It caused no change in cerebral blood flow in a study of patients receiving approximately 1.5 MAC of total inhaled anesthesia (isoflurane added to N20) with concomitant hyperventilation (7). This coupled with the observed 50% reduction in cerebral metabolic rate would suggest the safety of the use of isoflurane for neuroanesthesia (8). However, other studies have shown that small-dose isoflurane may cause an increase in ICI' in patients with malignant brain tumors, despite prior, modest hyperventilation (9). Thus, although isoflurane may be an appropriate volatile anesthetic for neuroanesthesia, its safety cannot be assured under all conditions. Therefore, the present study chose to limit the concentration of isoflurane to 1 MAC for maintenance anesthesia for patient care considerations.
STP has been used to control the hyperdynamic effects of noxious stimuli for neurosurgical procedures. However, its use is not without deleterious sequelae. One major disadvantage of barbiturates is dose-dependent cardiovascular depression. Myocardial contractility is decreased owing to a lack of available calcium, and peripheral vasodilation occurs secondary to lowered sympathetic tone, both of which will result in a reduction in blood pressure (8). In the hemodynamically compromised or hypovolemic patient, the decrease in blood pressure can be dramatic. Moreover, when large or repeated doses of STP are used, zero-order kinetics are followed with a t,;,s NEUROSURGICAL ANESTHESIA PINOSKY ET AL. 
